Background: Deep brain stimulation (DBS) is a typical intervention treating drug-refractory
dystonia. Currently, the selection of the better target, the GPi or STN, is debatable. The …

Deep brain stimulation in dystonia: factors contributing to... : Current Opinion in Neurology
Deep brain stimulation in dystonia: factors contributing to variability in outcome in short and …

Objective Genetic subtypes of dystonia may respond differentially to deep brain stimulation
of the globus pallidus pars interna (GPi DBS). We sought to compare GPi DBS outcomes …

Background Non-spastic movement disorders in children are common, although true
epidemiologic data is difficult to ascertain. Children are more likely than adults to have …

Background Deep brain stimulation (DBS) is an effective intervention for Meige syndrome, a
type of dystonia characterized by blepharospasm, facial, and oromandibular dystonia. This …

Dystonia is one of the most common pediatric movement disorders and can have a profound
impact on the lives of children and their caregivers. Response to pharmacologic treatment is …

Background This review highlights the recent scientific advances that have enabled rational
design of novel clinical trials for pantothenate kinase‐associated neurodegeneration …

Background: Rare movement disorders (RMDs) throw remarkable challenges to their
appropriate management particularly when they are medically refractory. We studied the …

Objective Dystonia in pantothenate kinase-associated neurodegeneration (PKAN) is
progressive despite medication. Deep brain stimulation (DBS) was reported to effectively …

Objective This study aimed to explore the efficacy and safety of pantethine in children with
pantothenate kinase-associated neurodegeneration (PKAN). Methods A single-arm, open …